The global Cancer Therapeutics Biotherapeutics Market experienced significant growth in 2022, reaching a valuation of USD 97.08 billion, and is projected to continue its upward trajectory, reaching a staggering USD 252.39 billion by 2032. This remarkable expansion is anticipated to be fueled by a robust compound annual growth rate (CAGR) of 6.9% throughout the forecast period. Several factors are converging to drive this growth, including the increasing prevalence of cancer on a global scale, escalating healthcare expenditures, and significant advancements in the realm of cancer research and treatment. https://www.reportsanddata.com/report-detail/cancer-therapeutics-biotherapeutics-market